LUOXIN PHARMACEUTICAL
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

LUOXIN PHARMACEUTICAL Trademark

Serial Number: 79267215 • Registration: 6181988

LUOXIN PHARMACEUTICAL is a trademark filed by SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., LTD. on July 18, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., LTD.

Luo 7 Road
Shandong 276017 , CN

Entity Type: 99

Trademark Details

Filing Date

July 18, 2019

Registration Date

October 27, 2020

Published for Opposition

August 11, 2020

Goods & Services

Pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for peripheral nervous system; medicinal tea; Chinese medicine nostrum in the nature of natural remedy preparations for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, cerebral ischemia, prostate disease, infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; medicinal herbs; biochemical medicines for the treatment of pneumonia, urinary tract infection, gynecological infections, skin and skin structure infections, meningitis, septicemia, cancer, diabetes, prostate disease, infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; biochemical drugs for treatment of gastrointestinal diseases; antiseptics; dental lacquer; diapers for pets; medicinal alcohol; medicinal oils; amino acids for medical purposes

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 27, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 7, 2021 FINV
GENERIC MADRID TRANSACTION SENT TO IB
Feb 9, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 9, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 27, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 27, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 11, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Aug 7, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 22, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 22, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 8, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 8, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 8, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 8, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 8, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 8, 2020 TROA
REFUSAL PROCESSED BY IB
Mar 27, 2020 RFNT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 20, 2020 GNRN
NON-FINAL ACTION E-MAILED
Feb 20, 2020 GNRT
NON-FINAL ACTION WRITTEN
Feb 20, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2020 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 26, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 26, 2019 CRFA
ASSIGNED TO LIE
Dec 23, 2019 ALIE
REFUSAL PROCESSED BY IB
Dec 14, 2019 RFNT
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 8, 2019 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 27, 2019 RFCS
REFUSAL PROCESSED BY MPU
Nov 27, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 5, 2019 RFCR
NON-FINAL ACTION WRITTEN
Nov 4, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 4, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 24, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 17, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 12, 2019 REPR